Profile for Australia Patent: 2020267186
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2020267186
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,357,567 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| 11,077,192 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| 11,135,293 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| 11,571,478 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| 11,690,914 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| 12,296,011 | Jan 12, 2038 | Sun Pharm Inds Inc | LEVULAN | aminolevulinic acid hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
